Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis

BACKGROUND AND AIMS: There are limited comparative data for infliximab and vedolizumab in inflammatory bowel disease patients. METHODS: We conducted a systematic review and meta-analysis to compare the efficacy and safety of infliximab and vedolizumab in adult patients with moderate-to-severe Crohn’...

Descripción completa

Detalles Bibliográficos
Autores principales: Peyrin-Biroulet, Laurent, Arkkila, Perttu, Armuzzi, Alessandro, Danese, Silvio, Guardiola, Jordi, Jahnsen, Jørgen, Lees, Charles, Louis, Edouard, Lukáš, Milan, Reinisch, Walter, Roblin, Xavier, Jang, Minyoung, Byun, Han Geul, Kim, Dong-Hyeon, Lee, Sung Jeong, Atreya, Raja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178865/
https://www.ncbi.nlm.nih.gov/pubmed/35676620
http://dx.doi.org/10.1186/s12876-022-02347-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178865/
https://www.ncbi.nlm.nih.gov/pubmed/35676620
http://dx.doi.org/10.1186/s12876-022-02347-1

Ejemplares similares